Stock listing
A2PLTK Stock Price, News, Filings & Events — Personalis, Inc.
Selected listing: A2PLTK · LS · EUR · DE
This page tracks Personalis, Inc.'s A2PLTK:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2PLTK:LS. A2PLTK:LS is the stock-level entry point for investors researching Personalis, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Personalis, Inc. (ticker: PSNL) is a public company based in the United States, specializing in genomics and personalized medicine. With a market capitalization of approximately $1.26 billion, the company focuses on providing advanced genomic sequencing and analysis services to enhance cancer treatment and precision medicine. Personalis aims to improve patient outcomes through innovative technology and data-driven insights.
- Ticker
- A2PLTK:LS
- Asset type
- Stock
- Market cap
- $1.82B
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- LS
- Currency
- EUR
Personalis, Inc. A2PLTK:LS stock context
This page tracks Personalis, Inc.'s A2PLTK:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2PLTK:LS. A2PLTK:LS is the stock-level entry point for investors researching Personalis, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Personalis, Inc. (ticker: PSNL) is a public company based in the United States, specializing in genomics and personalized medicine. With a market capitalization of approximately $1.26 billion, the company focuses on providing advanced genomic sequencing and analysis services to enhance cancer treatment and precision medicine. Personalis aims to improve patient outcomes through innovative technology and data-driven insights.
Latest news from Personalis, Inc.
Personalis Accelerates Global Expansion with UKCA Marking for NeXT Personal®, Expanding MRD Access and Biopharma Support in Great Britain
July 14, 2026
Personalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection Kits
June 9, 2026
Personalis Highlights Early Colorectal Cancer Recurrence Detection and Ultrasensitive MRD Performance Across a Broad Set of Tumor Types a...
June 2, 2026
Personalis to Highlight Breadth of NeXT Personal® Ultra-Sensitive ctDNA Data at ASCO 2026 Annual Meeting, Including Podium Presentation f...
May 26, 2026
Personalis Secures Fourth Medicare Coverage Decision for NeXT Personal®, Expanding Breast Cancer Coverage to Pre-Surgical Treatment Monit...
May 20, 2026
Personalis, Inc. earnings calls
Personalis, Inc. (PSNL) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Personalis, Inc. (PSNL) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
Personalis, Inc. (PSNL) Q1 2025 Earnings Call
May 6, 2025 · Replay with transcript and chapters
Personalis, Inc. (PSNL) Q4 2024 Earnings Call
February 27, 2025 · Replay with transcript and chapters
Personalis, Inc. (PSNL) Q3 2024 Earnings Call
November 6, 2024 · Replay with transcript and chapters
Personalis, Inc. (PSNL) Q2 2024 Earnings Call
August 7, 2024 · Replay with transcript and chapters
Research Personalis, Inc.
Personalis, Inc. investor report
Review AI stock analysis and investor report context for A2PLTK:LS.
Personalis, Inc. company profile
View the public company page for Personalis, Inc. on 6ix.
Personalis, Inc. news
Read company news and market updates connected to Personalis, Inc..
Personalis, Inc. investor events
Find investor webinars, events, and replay context for Personalis, Inc..
Alternate listings
PSNL:NASDAQ
US · USD
Alternate listing for Personalis, Inc.; the primary context on this page is A2PLTK:LS.
04X:TRADEGATE
DE · EUR
Alternate listing for Personalis, Inc.; the primary context on this page is A2PLTK:LS.
04X:GETTEX
DE · EUR
Alternate listing for Personalis, Inc.; the primary context on this page is A2PLTK:LS.
A2PLTK:LSX
DE · EUR
Alternate listing for Personalis, Inc.; the primary context on this page is A2PLTK:LS.
PSNL:BOATS
US · USD
Alternate listing for Personalis, Inc.; the primary context on this page is A2PLTK:LS.
04X:FWB
DE · EUR
Alternate listing for Personalis, Inc.; the primary context on this page is A2PLTK:LS.
04X:DUS
DE · EUR
Alternate listing for Personalis, Inc.; the primary context on this page is A2PLTK:LS.
04X:HAM
DE · EUR
Alternate listing for Personalis, Inc.; the primary context on this page is A2PLTK:LS.
04X:MUN
DE · EUR
Alternate listing for Personalis, Inc.; the primary context on this page is A2PLTK:LS.
04X:SWB
DE · EUR
Alternate listing for Personalis, Inc.; the primary context on this page is A2PLTK:LS.